Who founded Cytodyme?

Cytodyme was founded by Tammy Ogden, Dennis White in 2024.

Who are Cytodyme's investors?

Cytodyme's investors include Techstars.

How much funding has Cytodyme raised?

Cytodyme has disclosed $75K raised across 1 round.

Where is Cytodyme headquartered?

Cytodyme is headquartered in San Diego, US.

Cytodyme

Techstars '25

San Diego, US · Founded 2024 · Delaware corporation · 5 employees on LinkedIn · 1 known investors

Find your way into Cytodyme

529 people in our graph share verified history with the Cytodyme team — schools, employers, funds. One of them is your warm intro.

Rustyunlockedknows Dennis White · together at Techstars (overlapped)

×9knows the team · via Techstars

×2knows the team · via UCLA

Cytodyme builds software for regulatory and quality teams at life science companies to manage post-market reporting, literature reviews, documentation, audits, and submissions. The platform consolidates data from disconnected systems to reduce administrative burden for regulated life science and biotech teams.

AI & Machine Learning Biotech Healthtech LegalTech Medical Devices SaaS

Founders & leadership

Cytodyme was founded in 2024 by Tammy Ogden and Dennis White.

Tammy OgdeninCo-Founder @ Cytodyme

Dennis White inCo-founder · Chief Executive OfficerDennis White serves as CEO of Cytodyme. He has over 10 years of experience in biopharmaceutical development, including roles at Kite Pharma and Immunity Bio focused on cell and gene therapy, and is pursuing an MBA from the University of California San Diego.

Stephen Brown-BourneinCo-Founder / CTO2025–2026

Investors · 1

Techstars✓ verifiedBoulder · $220K

Reported raises · per SEC filings

Form D private placements

$75K disclosed across 1 round · 2026

▶$75KraisedFeb 2026 · 3 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Tammy OgdenExecutive Officer, Director
Stephen Brown-BourneExecutive Officer, Director
Dennis WhiteExecutive Officer, Director

Offering amount: $2.5M
Amount sold: $75K
First sale: Jan 2026
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Kite Pharma3 shared keywordsKite develops CAR T-cell therapies that engineer a patient's own immune cells to target and destroy cancer cells. The company focuses on cell therapy treatments for cancers such as diffuse large B-cell lymphoma.

CytomX3 shared keywordsCytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue. It advances a pipeline of Probody therapeutics through preclinical research and clinical trials in oncology.

Companies competing with Cytodyme for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Cytodyme do?: Cytodyme builds software for regulatory and quality teams at life science companies to manage post-market reporting, literature reviews, documentation, audits, and submissions. The platform consolidates data from disconnected systems to reduce administrative burden for regulated life science and biotech teams.
Who founded Cytodyme?: Cytodyme was founded by Tammy Ogden, Dennis White in 2024.
Who are Cytodyme's investors?: Cytodyme's investors include Techstars.
How much funding has Cytodyme raised?: Cytodyme has disclosed $75K raised across 1 round.
Where is Cytodyme headquartered?: Cytodyme is headquartered in San Diego, US.